All ESG and regulatory drivers articles
-
NewsUpcycled plastic could facilitate production of Parkinson’s drug
Bioengineered E.coli provide an eco alternative to creating L-DOPA from terephthalic acid, suggests study.
-
NewsNanofiltration study highlights next-generation water treatment process
The technology could offer defect-free, high-efficiency ceramic-based water filtration through ultra-precise control of nanopores and surface structure.
-
ArticleThe implementation of biodiversity footprinting – examining supply chains
Carbon accounting is a well recognised means of assessing environmental impact in terms of greenhouse gas emissions, but the ecological effects from business practices are far broader. Dr Tara Garraty reveals how biodiversity footprinting serves to paint a more complete picture.
-
NewsEU court dismisses pharma call to annul disputed wastewater rules
Ruling leaves “important legal questions regarding the validity of the Directive unresolved”, according to industry association EFPIA.
-
NewsLeftover bread could support sustainable pharmaceutical manufacturing
The use of microbial-derived hydrogen could lead to carbon-negative, fossil-free bioproduction of pharmaceuticals.
-
NewsFujifilm Biotechnologies inaugurates expanded £400m UK biomanufacturing site
The CDMO’s investment in the North-East based site expansion supports UK production of medicines and vaccines.
-
NewsEndotoxins research supports recombinant reagent use for pharma QC
Replacing LAL reagents with animal-free alternatives addresses industry commitments to improve QC practices’ ethics and sustainability.
-
NewsChemical assessment in Europe to be streamlined under new legislation
The European Commission’s new framework aims to improve safety assessment of chemicals to better protect human health and the environment.
-
NewsEndotoxin testing milestone reached with European Pharmacopoeia’s animal shift
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
-
WebinarIncreasing the effectiveness of pharma endotoxin testing
During this virtual panel, industry experts will discuss the evolution of endotoxin testing, future trends and key risk mitigation considerations for pharma companies.
-
-
NewsBSI launches a world-first environmental standard for the pharma industry
New BSI standard PAS 2090 could reshape how the pharmaceutical industry reports and minimises its environmental footprint.
-
News
Chiesi gains pace on climate target with new carbon minimal inhaler data
Findings presented at the British Thoracic Society (BTS) Winter Meeting back biopharma’s Net Zero commitment.
-
NewsMedicines manufacturing in the UK to receive £54m sustainability boost
R&D projects supported by the Centre for Process Innovation (CPI) aim to shape a sustainable, resilient and competitive future for pharma manufacturing.
-
NewsPharma's sustainability push continues as Merck signs renewable energy deal
The German pharma company’s agreement for its South Korea sites is the latest green initiative to be unveiled by the industry.
-
NewsChiesi completes expansion of French metered dose inhaler facility
The enlarged La Chaussée-Saint-Victor site will serve as a manufacturing hub for the biopharma company.
-
NewsRentschler Biopharma marks construction milestone at new German buffer media facility
The new biopharmaceutical production facility represents the CDMO’s largest single investment at its headquarters in Lauphei, Germany.
-
NewsTakeda eyes sustainable shipping with wind-powered sea freight
Partners with Vela for transatlantic medicine transportation using its cargo trimaran.
-
NewsMerck opens €150m climate-neutral filter manufacturing facility in Ireland
The German pharma company will create over 200 jobs at its new Blarney site in Cork.
-
WebinarThe future of sterility testing: one-day results with advanced RT-rt PCR technology
Watch this webinar to find out how RT-rt PCR is revolutionising sterility testing and discover a unique approach that provides reliable one-day results and enhanced sensitivity and detection capabilities.